학술논문

Exploratory Biomarker Analysis Using Plasma Angiogenesis-Related Factors and Cell-Free DNA in the TRUSTY Study: A Randomized, Phase II/III Study of Trifluridine/Tipiracil Plus Bevacizumab as Second-Line Treatment for Metastatic Colorectal Cancer
Document Type
Article
Source
In: Targeted Oncology. (Targeted Oncology, January 2024, 19(1):59-69)
Subject
Language
English
ISSN
1776260X
17762596